Auctus Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$854K Buy
10,010
+10
+0.1% +$905 0.69% 7
2026
Q2
$917K Hold
10,000
– – 0.77% 7
2026
Q1
$852K Hold
10,000
– – 0.81% 8
2025
Q4
$790K Buy
+10,000
New +$784K 0.73% 7

Other funds holding CL

Auctus Advisors's CL Position: Q3 2026 in Review

Auctus Advisors increased its Colgate-Palmolive (CL) stake by 0.1% in Q3 2026, buying an estimated $905 and bringing the position to 10,010 shares worth $854K. The position accounts for 0.69% of the portfolio, ranked #7.

Auctus Advisors first reported a position in CL in Q4 2025 and has held it in 4 quarters since. The position peaked at $917K in Q2 2026. 1,958 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Auctus Advisors held 10,010 shares of Colgate-Palmolive worth $854K as of Q3 2026.
  • Auctus Advisors bought 10 Colgate-Palmolive shares in Q3 2026, an estimated $905.
  • Colgate-Palmolive made up 0.69% of Auctus Advisors's portfolio in Q3 2026, its #7 holding.
  • Auctus Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 4 quarters since.
  • Auctus Advisors's Colgate-Palmolive position peaked at $917K in Q2 2026.
  • 1,958 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Auctus Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.